High detection rates of antithrombin deficiency and antiphospholipid syndrome in outpatients aged over 50 years using the standardized protocol for thrombophilia screening

Thrombosis Research

Volumn 176, Issue , 2019, Pages 67-73

  Goldman Mazur, Sarah ^a,b   Wypasek, Ewa ^a,c   Karpiński, Marek ^a   Stanisz, Andrzej ^d   Undas, Anetta ^a,d  

^a Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^c ANDRZEJ FRYCZ MODRZEWSKI KRAKOW UNIVERSITY   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antiphospholipid syndrome; Antithrombin deficiency; Thrombophilia; Thrombophilia screening; Venous thromboembolism

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTHROMBIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN DEFICIENCY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT; PATIENT COMPLIANCE; POPULATION RESEARCH; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; SCREENING TEST; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; AGE; AGED;

ADULT; AGE FACTORS; AGED; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN III DEFICIENCY; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 85061543671     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2019.02.008     Document Type: Article

References (30)

1. Connors, J.M., Thrombophilia testing and venous thrombosis. N. Engl. J. Med., 377, 2017, 2298.
2. Middeldorp, S., Evidence-based approach to thrombophilia testing. J. Thromb. Thrombolysis 31 (2011), 275–281.
3. Mannucci, P.M., Franchini, M., Classic thrombophilic gene variants. Thromb. Haemost. 114 (2015), 885–889.
4. Andreoli, L., Chighizola, C.B., Banzato, A., Pons-Estel, G.J., Ramire de Jesus, G., Erkan, D., Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res. 65 (2013), 1869–1873.
5. Wypasek, E., Corral, J., Alhenc-Gelas, M., Sydor, W., Iwaniec, T., Celinska-Lowenhoff, M., et al. Genetic characterization of antithrombin, protein C, and protein S deficiencies 8 patients. Pol Arch Intern Med. 127 (2017), 512–523.
6. Baglin, T., Gray, E., Greaves, M., Hunt, B.J., Keeling, D., Machin, S., et al. Clinical guidelines for testing for heritable thrombophilia. Br. J. Haematol. 149 (2010), 209–220.
7. Pengo, V., Tripodi, A., Reber, G., Rand, J.H., Ortel, T.L., Galli, M., et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 7 (2009), 1737–1740.
8. Nicolaides, A.N., Breddin, H.K., Carpenter, P., Coccheri, S., Conard, J., De Stefano, V., et al. Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int. Angiol. 24 (2005), 1–26.
9. Van Cott, E.M., Laposata, M., Prins, M.H., Laboratory evaluation of hypercoagulability with venous or arterial thrombosis. Arch. Pathol. Lab. Med. 126 (2002), 1281–1295.
10. Kwon, A.J., Roshal, M., DeSancho, M.T., Clinical adherence to thrombophilia screening guidelines at a major tertiary care hospital. J. Thromb. Haemost. 14 (2016), 982–986.
11. Meyer, M.R., Witt, D.M., Delate, T., Johnson, S.G., Fang, M., Go, A., et al. Thrombophilia testing patterns amongst patients with acute venous thromboembolism. Thromb. Res. 136 (2015), 1160–1164.
12. Roldan, V., Lecumberri, R., Muñoz-Torrero, J.F., Vicente, V., Rocha, E., Brenner, B., et al. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb. Res. 124 (2009), 174–177.
13. Hatano, S., Experience from a multicentre stroke register: a preliminary report. Bull. World Health Organ. 54 (1976), 541–553.
14. Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4 (2006), 295–306.
15. Cattaneo, M., Hyperhomocysteinemia and venous thromboembolism. Semin. Thromb. Hemost. 32 (2006), 716–723.
16. Undas, A., Stepień, E., Plicner, D., Zielinski, L., Tracz, W., Elevated total homocysteine is associated with increased platelet activation at the site of microvascular injury: effects of folic acid administration. J. Thromb. Haemost. 5 (2007), 1070–1072.
17. Chighizola, C.B., Ubiali, T., Meroni, P.L., Treatment of thrombotic antiphospholipid syndrome: the rationale of current management-an insight into future approaches. J Immunol Res, 2015, 2015, 951424.
18. Croles, F.N., Borjas-Howard, J., Nasserinejad, K., Leebeek, F.W.G., Meijer, K., Risk of venous thrombosis in antithrombin deficiency: a systematic review and Bayesian meta-analysis. Semin. Thromb. Hemost. 44 (2018), 315–326.
19. Morris, J.G., Singh, S., Fisher, M., Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good?. Stroke 41 (2010), 2985–2990.
20. Pahus, S.H., Hansen, A.T., Hvas, A.M., Thrombophilia testing in young patients with ischemic stroke. Thromb. Res. 137 (2016), 108–112.
21. Schreiber, K., Sciascia, S., de Groot, P.G., Devreese, K., Jacobsen, S., Ruiz-Irastorza, G., et al. Antiphospholipid syndrome. Nat Rev Dis Primers., 4, 2018, 18005.
22. Bleker, S.M., Coppens, M., Middeldorp, S., Sex, thrombosis and inherited thrombophilia. Blood Rev. 28 (2014), 123–133.
23. Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ, 342, 2011, d813.
24. Weingarz, L., Schwonberg, J., Schindewolf, M., Hecking, C., Wolf, Z., Erbe, M., et al. Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry. Br. J. Haematol. 163 (2013), 655–665.
25. den Heijer, M., Koster, T., Blom, H.J., Bos, G.M., Briet, E., Reitsma, P.H., et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N. Engl. J. Med. 334 (1996), 759–762.
26. Eichinger, S., Stumpflen, A., Hirschl, M., Bialonczyk, C., Herkner, K., Stain, M., et al. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb. Haemost. 80 (1998), 566–569.
27. Jenkins, P.V., Rawley, O., Smith, O.P., O'Donnell, J.S., Elevated factor VIII levels and risk of venous thrombosis. Br. J. Haematol. 157 (2012), 653–663.
28. O'Donnell, J., Tuddenham, E.G., Manning, R., Kemball-Cook, G., Johnson, D., Laffan, M., High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb. Haemost. 77 (1997), 825–828.
29. Lonn, E., Yusuf, S., Arnold, M.J., Sheridan, P., Pogue, J., Micks, M., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354 (2006), 1567–1577.
30. Sokol, J., Timp, J.F., le Cessie, S., van Hylckama-Vlieg, A., Rosendaal, F.R., Kubisz, P., et al. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study. J. Thromb. Haemost. 16 (2018), 680–688.